Oct 1, 2026 04:00PM
Aug 5, 2026 04:03PM
Aug 5, 2026 04:01PM
Jul 29, 2026 04:02PM
Jul 29, 2026 04:01PM
May 6, 2026 05:56PM
May 6, 2026 04:01PM Xencor Reports First Quarter 2026 Financial Results
Feb 25, 2026 04:01PM
Jan 8, 2026 08:11AM
Jan 8, 2026 08:01AM
Nov 5, 2025 05:53PM
Nov 5, 2025 04:01PM
Aug 6, 2025 06:23PM
Aug 6, 2025 04:01PM Xencor Reports Second Quarter 2025 Financial Results
May 7, 2025 06:04PM
May 7, 2025 04:01PM
Feb 28, 2025 04:38AM
Feb 27, 2025 08:01AM
Nov 7, 2024 10:19AM
Nov 6, 2024 04:02PM
Nov 6, 2024 04:01PM Xencor Reports Third Quarter 2024 Financial Results
Aug 5, 2024 04:17PM
Aug 5, 2024 04:01PM
May 9, 2024 04:48PM
May 9, 2024 04:09PM
Feb 28, 2024 07:24AM
Feb 27, 2024 04:09PM
Feb 27, 2024 04:01PM Xencor Reports Fourth Quarter and Full Year 2023 Financial Results
Feb 20, 2024 04:31PM
Nov 7, 2023 04:18PM
Nov 7, 2023 04:01PM
Oct 31, 2023 04:01PM
Aug 3, 2023 04:25PM
Aug 3, 2023 04:01PM
Jul 27, 2023 08:01AM Xencor to Host Second Quarter 2023 Financial Results Webcast and Conference Call on August 3, 2023
May 8, 2023 05:06PM
May 8, 2023 04:01PM
May 1, 2023 04:01PM
Feb 23, 2023 04:26PM
Feb 23, 2023 04:01PM
Feb 16, 2023 04:01PM
Nov 7, 2022 04:02PM Xencor (XNCR) Announces XmAb564 is Well-tolerated and Selectively Expands Regulatory T Cells in Phase 1a Clinical Study
Nov 7, 2022 04:01PM
Nov 7, 2022 04:01PM
Oct 31, 2022 04:01PM
Aug 3, 2022 04:39PM
Aug 3, 2022 04:01PM
Jul 27, 2022 04:01PM
May 5, 2022 04:47PM Xencor (XNCR) Tops Q1 EPS by 99c
May 5, 2022 04:01PM

1,231,050 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All